EUVIMEDEUVIMED entdecken
Crossref

Quantitative analysis of the impact of membrane permeability on intestinal first‐pass metabolism of CYP3A substrates

Yugo Yasugi iD, Yoshiyuki Shirasaka, Ikumi Tamai

Biopharmaceutics & Drug Disposition · 2024

DOI: 10.1002/bdd.2379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biopharmaceutics & Drug Disposition, 2024. Verfasst von Yugo Yasugi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Intestinal Absorption. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, JST SPRING.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was firstly to investigate the effect of membrane permeability on the intestinal availability ( F g ) of 10 cytochrome P450 3A4 substrates with differing permeability ( P app ) and metabolic activity ( CL int ) using Madin‐Darby canine kidney II (MDCKII) cells expressing human CYP3A4 (MDCKII/CYP3A4 cells), and secondly to confirm the essential factors by simulations. A membrane permeation assay using MDCKII/CYP3A4 cells showed a significant correlation between human intestinal extraction ratio (ER) ( E g (=1 − F g )) and in vitro cellular ER ( r = 0.834). This relationship afforded better predictability of E g values than the relationship between E g and CL int,HIM values obtained from human intestinal microsomes ( r = 0.598). An even stronger correlation was observed between 1 − F a · F g and ER ( r = 0.874). Simulation with a cellular kinetic model indicated that ER is sensitive to changes of PS passive and CL int values, but not to the intracellular unbound fraction ( f u,cell ) or P‐gp‐mediated efflux ( PS P − gp ). It may be concluded that, based on the concentration–time profile of drugs in epithelial cells, transmembrane permeability influences F g (or ER) and drug exposure time to metabolizing enzymes for P450 substrate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP3AIntestinal AbsorptionHumansAnimalsDogsIntestinesCell Membrane PermeabilityPermeability

Stichwörter der Autor:innen

CYP3A4first-pass metabolismintestinal absorptionintestinal metabolismmodeling & simulation

Substanzen

Cytochrome P-450 CYP3A

Autor:innen und Institutionen

  • Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.

ORCID-Profile: Yugo Yasugi

Förderung

  • Japan Society for the Promotion of Science
  • JST SPRING

Zitieren

APA

Yasugi, Y., Shirasaka, Y., & Tamai, I. (2024). Quantitative analysis of the impact of membrane permeability on intestinal first‐pass metabolism of CYP3A substrates. Biopharmaceutics & Drug Disposition. https://doi.org/10.1002/bdd.2379

Vancouver

Yasugi Y, Shirasaka Y, Tamai I. Quantitative analysis of the impact of membrane permeability on intestinal first‐pass metabolism of CYP3A substrates. Biopharmaceutics & Drug Disposition. 2024. doi:10.1002/bdd.2379

BibTeX
@article{Yasugi2024,
  author = {Yasugi, Yugo and Shirasaka, Yoshiyuki and Tamai, Ikumi},
  title = {Quantitative analysis of the impact of membrane permeability on intestinal first‐pass metabolism of CYP3A substrates},
  journal = {Biopharmaceutics & Drug Disposition},
  year = {2024},
  doi = {10.1002/bdd.2379}
}
Kostenlos starten →